Evidence map›Paper›PMID 42281475›Full record

Observational studyCancer reports (Hoboken, N.J.)2026

Epidemiological Trends and Burden of Adult Kidney Cancer in Saudi Arabia: A 42-Year Retrospective Analysis (1982-2023).

Arwa F Flemban, Saeed M Kabrah, Hanaa Alahmadi, Lama S Alahdali, Lama S Maksood, May A Alqurashi, Omnia J Kutbi, Hanan M Abd Elmoneim, Abdulaziz Bakhsh, Turky Almouhissen and 3 more

Abstract readObservational Study
In one paragraph

Observational study in Cancer reports (Hoboken, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Arwa F FlembanDepartment of Pathology, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.ORCID 0000-0001-8761-4280
Saeed M KabrahDepartment of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.ORCID 0000-0003-2992-8497
Hanaa AlahmadiDepartment of Pathology, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.ORCID 0000-0001-8252-9941
Lama S AlahdaliFaculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.ORCID 0009-0006-7637-0368
Lama S MaksoodFaculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.ORCID 0000-0002-4391-1555
May A AlqurashiFaculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.ORCID 0009-0005-1480-4450
Omnia J KutbiFaculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.
Hanan M Abd ElmoneimDepartment of Pathology, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.ORCID 0000-0003-1715-5060
Abdulaziz BakhshGeneral and Specialized Surgery Department, College of Medicine, Taibah University, Madinah, Saudi Arabia.ORCID 0009-0000-8944-0050
Turky AlmouhissenCollege of Medicine, University of Jeddah, Jeddah, Saudi Arabia.ORCID 0009-0003-2158-6135
Samar Nabeel EkramDepartment of Genetics, College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.ORCID 0000-0002-2337-7172
Halah T AlbarDepartment of Physiology, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.ORCID 0009-0009-0753-7453
Waseem TayebDepartment of Surgery, Division of Urology, King Abdullah Medical City at Holy Capital, Makkah, Saudi Arabia.ORCID 0009-0006-0805-7011

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCancer epidemiology differs between males and females due to variation in exposure to risk factors. Kidney cancer incidence and mortality have increased globally, yet long-term sex-specific trends in Saudi Arabia remain insufficiently characterised. Kidney cancer incidence in Saudi Arabia has increased steadily over time, with an average annual percentage change (APC) of 3.22% over the study period.

aimThis study aimed to analyse long-term trends in kidney cancer burden in Saudi Arabia and to compare incidence, mortality, years of life lost (YLLs) and disability-adjusted life years (DALYs) by sex over the period 1982-2023.

methodsA retrospective observational study was conducted using non-overlapping data from the Saudi Cancer Registry and the Global Burden of Disease 2021 study. Adults aged 20 years and older diagnosed with kidney cancer between 1982 and 2023 were included. Age-standardised incidence, mortality, YLLs and DALYs were analysed by sex. Temporal trends were assessed using log-linear regression models and APC was calculated.

resultsA cumulative total of 34 247 adult kidney cancer cases was identified between 1982 and 2023. Over the 42-year period, incidence increased by 3.22% annually. The increase was faster in females than in males (3.65% vs. 2.99%, p < 0.001). YLLs rose by 1.45% per year and DALYs by 1.73%, both showing greater increases among females. Despite this, the overall burden remained consistently higher in males across all indicators. Disease burden increased progressively with age and was highest in older adult populations.

conclusionKidney cancer burden has increased substantially in Saudi Arabia over the past four decades. Although males experience a higher overall burden, females show a faster rate of increase. These findings highlight the need for sex-specific prevention strategies, improved early detection, and strengthened national surveillance. Addressing modifiable risk factors such as smoking, obesity and hypertension remains a priority for public health intervention.

Indexed as

Kidney NeoplasmsAdultAgedDisability-Adjusted Life YearsFemaleHumansIncidenceMaleMiddle AgedRegistriesRetrospective StudiesRisk FactorsSaudi ArabiaSex FactorsYoung Adultepidemiologykidney cancerrenal cell carcinomaSaudi Arabia

Identifiers

PMID42281475
PMCPMC13261299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.